Member Info for scardey_cat

The Ask jumped 15% at 4:20pm on no volume. Be interesting to see if there's a rather large late reported trade.

I agree @Codejunkie. I'm merely talking about primary market focus.

I think the transitioning of this company from an LFT investment to a therapeutics investment, will happen sooner than we think. The market's currently trying to decide which one it is. When it happens, we will start to see true value here again, with LFT providing a significant slingshot to the SP when even the most minor positive news arrives on the LFT front.

Done helmet.

I gave my brother some updated guidance today @BigDano. Not too excited by this 'lead', but worth an enquiry nonetheless.

Cheers Peter. No big deal, just when you're passing.
Probably a misguided bulletin board post, but having said that, Avacta did do their test validation at La Paz Hospital, Madrid, so you never know. ISS charge 55 Euros for an antigen rapid test...cheeky...you can buy them online for about £8!
If you do bob in, ask them what brand of antigen rapid test they're selling.
If it is Avacta, ask them how many outlets they have in Spain and if they're selling in big numbers.
Avacta's test is called AffiDX. Ask them if they've heard of it.
Good opportunity to practice your Spanish :-)
Hope the back improves soon.

Doesn't just happen on AIM @Apre. I still have a £97k loss on NMC showing in my SIPP account (company shares suspended...in administration...ongoing court proceedings etc...very little chance of recovering anything). That was a FTSE100 company, supposedly audited by Ernst Young a few months prior to it's downfall, who rather carelessly neglected to spot a £7bn hole in the accounts.

Just looking at the sub £1 trades today, I see that prior to the 99.7k buy at 08:14, there were a total of £113k trades sub £1 (I assume most of these were stop losses triggered, since it was impossible to buy sub £1). So, it looks like that was a smash and grab to fill the 99.7k order. Will be interesting to see if pattern repeats tomorrow.

@Awful
"I read this board from time to time, as I know someone who works at Avacta and I like sending them screengrabs."

If you do know somebody that works at Avacta, perhaps you can find out what happened to Amriq.

Actually, did mathematics at Uni, but had to refresh myself on Fibonacci sequences. If it wasn't a modified Fibonacci sequence, then we could surmise the dosing will be:
80,80,160,240,420,660
(next number in the sequence is the sum of the previous two).
Anyway, it's a modified sequence, so could be anything :-)

Ah, I wondered why people kept using names (plural). I hadn't noticed the SAB members had disappeared too.
So, people would have us believe 5 people have suddenly left. If you believe that, you may as well believe @Energy's pot hole story.
Obviously, it's just a website re-organisation and they'll probably pop up on a separate page.

Don't know if already posted, but just noticed this on Avacta LinkedIn page. Might give us some clues as to developments:

European Society for Clinical Virology
1 week ago

Be sure to add Industry Symposium 1 sponsored by Avacta on September 15 (12:40 - 13:40 BST) to your agenda! Join Dr Alastair Smith, Professor Matthew Baylis, and Dr Matt Johnson for a focused discussion on the challenge of future pandemics.

?? Link to register: https://lnkd.in/d3qaYKm

#ESCV2021 #ClinicalVirology #SARSCoV2 #Vaccines

You going to lend him a few quid @marik?

@Awfulinvestor
It was a no warning website update pal. We don't even know if he's gone, or not yet.
Don't know why you're trying to sew fear with your "It was a no warning departure. Rough.", as if he's at CFO, or CEO level.

He's a CSO:
"A chief scientific officer (CSO) is a position at the head of scientific research operations at organizations or companies performing significant scientific research projects."

He is/was involved on the research side of things, not product development, or delivery.
So, no big deal. They'll replace him as and when needed (if indeed he has left).
I'd say we're pretty much ahead of the game as far as research goes. We've got the boys back at Leeds Uni doing a lot of that for us.

Just downloaded all todays trades from London Stock Exchange and put them in timed order.
The first trade below £1 was 08:09:32, the last trade below £1 was 08:14:42...5 minutes.
The final sub £1 trade was a £99,700 purchase @99.70.
I think that gives a measure of the strong support around these levels.

Matt Johnson is CSO of the diagnostics division. He's still gainfully employed...not stuck down a hole, or anything.
https://avacta.com/diagnostics/

We don't know for sure if the therapeutics CSO has gone, or is stuck down a hole, or something. That could be a website glitch, retirement, career change...anything. So, it's silly to jump to conclusions when we have ONE missing photo.

Very funny @Energy...had a good giggle at that. Excellent.

I was fired as an altar boy aged 10 (doing a bit of pre-service wine tasting). Perhaps there's some lingering bad karma out there for me, embodied in 'The Bishop'. Crazy, I only took a few sips...it was far too sweet.

Half expecting a TR1 from Conifer at some point. We don't know that they reduced any further from 2.99%, so would only take an approx £350k purchase to trigger a >3% TR1, if they didn't. I think it was accepted at the time that they invested for oncology, rather than LFT. So, if they were interested in oncology over a year ago @£1.20, no reason to believe they'd be less interested at this stage with phase 1 trial commenced. I suppose it will depend on their current fund liquidity. I'm sure AS must have been on the blower to them to discuss.

@Toukan
My brothers reply from yesterday:

"Hi Martin
Been laid up today with a painful back, hoping for some improvement with rest but it usually takes a few days.
Noticed that clinic last week when l was mobile, will call in when l can and see what's what.
Yes it's demoralising the stockmarket - all last weeks gains lost and some more, back in the dark place. "

I think he will likely call in by Weds/Thurs, my guess. He has an interest in Avacta - I've been mithering him for over a year now! Don't want to push him on it, since I'm not convinced it's Avacta's test as it says 10-15mins on their website. I'll update either way as soon as I hear.

Yes, good point @Poker. I was forgetting about closed periods for director purchases.
Though it's a bit of a stretch to think it's been closed for the whole of the last 3 months.
Anyway, hopefully it's closed now because they've been told a cheque's in the post...you never know.

Can't help thinking the delayed payment is a bit of a spiteful act by HMG. I have a suspicion that ABDX were asked to participate in RTC Mark II, along with GAD and Omega, but they told HMG they were not interested having been royally shafted already with the ABC test. That might have soured relations a bit.

Hopefully, TT confirmation of Avacta test will give the SP a boost.

@benx4
That would be Robbo, you're talkin about. This was his post earlier today:

"Life savings nearly evaporated in 2 month.. love to see it thanks Avacta"

I guess he's not been in touch with his mate recently.